Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY, Kuo YC, Weng YI, Lai IL, Huang TH, Lin SP, Niu DM, Chen CS.
Prostate. 2012 Dec 1;72(16):1767-78. doi: 10.1002/pros.22530. Epub 2012 Apr 26.
Related citations
DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G.
Hum Mol Genet. 2011 Nov 15;20(22):4299-310. doi: 10.1093/hmg/ddr356. Epub 2011 Aug 11.
Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
Yuen WY, Lemmink HH, van Dijk-Bos KK, Sinke RJ, Jonkman MF.
Br J Dermatol. 2011 Dec;165(6):1314-22. doi: 10.1111/j.1365-2133.2011.10553.x. Epub 2011 Nov 17.
Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Ohashi H, Tanuma T, Sukawa Y, Suzuki H, Sasaki S, Imai K, Shinomura Y.
Int J Oncol. 2011 Sep;39(3):593-9. doi: 10.3892/ijo.2011.1048. Epub 2011 May 20.
Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.
Kiritsi D, Kern JS, Schumann H, Kohlhase J, Has C, Bruckner-Tuderman L.
J Med Genet. 2011 Jul;48(7):450-7. doi: 10.1136/jmg.2010.086751. Epub 2011 Feb 28.
Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer.
Kwon OH, Park JL, Kim M, Kim JH, Lee HC, Kim HJ, Noh SM, Song KS, Yoo HS, Paik SG, Kim SY, Kim YS.
Biochem Biophys Res Commun. 2011 Mar 25;406(4):539-45. doi: 10.1016/j.bbrc.2011.02.082. Epub 2011 Feb 21.
A novel LAMA3 mutation in a newborn with junctional epidermolysis bullosa herlitz type.
Mazzucchelli I, Garofoli F, Decembrino L, Castiglia D, Tadini G, Bellingeri A, Borghesi A, Tzialla C, Manzoni P, Stronati M.
Neonatology. 2011;99(3):188-91. doi: 10.1159/000314076. Epub 2010 Sep 25.
Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.
Pasmooij AM, Garcia M, Escamez MJ, Nijenhuis AM, Azon A, Cuadrado-Corrales N, Jonkman MF, Del Rio M.
J Invest Dermatol. 2010 Oct;130(10):2407-11. doi: 10.1038/jid.2010.163. Epub 2010 Jun 24.
The impact of luteal phase support on gene expression of extracellular matrix protein and adhesion molecules in the human endometrium during the window of implantation following controlled ovarian stimulation with a GnRH antagonist protocol.
Zhao Y, Garcia J, Kolp L, Cheadle C, Rodriguez A, Vlahos NF.
Fertil Steril. 2010 Nov;94(6):2264-71. doi: 10.1016/j.fertnstert.2010.01.068. Epub 2010 Mar 12.
Metastatic potential of melanoma cells is not affected by electrochemotherapy.
Todorovic V, Sersa G, Mlakar V, Glavac D, Flisar K, Cemazar M.
Melanoma Res. 2011 Jun;21(3):196-205. doi: 10.1097/CMR.0b013e328337abd7.
Identification of hypermethylated genes associated with cisplatin resistance in human cancers.
Chang X, Monitto CL, Demokan S, Kim MS, Chang SS, Zhong X, Califano JA, Sidransky D.
Cancer Res. 2010 Apr 1;70(7):2870-9. doi: 10.1158/0008-5472.CAN-09-3427. Epub 2010 Mar 9.
Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X, Chen X, Hu L, Han S, Qiang F, Wu Y, Pan L, Shen H, Li Y, Hu Z.
Gynecol Oncol. 2010 May;117(2):287-90. doi: 10.1016/j.ygyno.2010.01.020. Epub 2010 Feb 16.
Development and successful clinical application of preimplantation genetic haplotyping for Herlitz junctional epidermolysis bullosa.
Fassihi H, Liu L, Renwick PJ, Braude PR, McGrath JA.
Br J Dermatol. 2010 Jun;162(6):1330-6. doi: 10.1111/j.1365-2133.2010.09701.x. Epub 2010 Feb 15.
Herlitz junctional epidermolysis bullosa.
Laimer M, Lanschuetzer CM, Diem A, Bauer JW.
Dermatol Clin. 2010 Jan;28(1):55-60. doi: 10.1016/j.det.2009.10.006. Review.
A deregulated immune response to gliadin causes a decreased villus height in DQ8 transgenic mice.
D'Arienzo R, Stefanile R, Maurano F, Luongo D, Bergamo P, Mazzarella G, Troncone R, Auricchio S, David C, Rossi M.
Eur J Immunol. 2009 Dec;39(12):3552-61. doi: 10.1002/eji.200839161.
TNFR and LTbetaR agonists induce follicle-associated epithelium and M cell specific genes in rat and human intestinal epithelial cells.
Wang J, Lopez-Fraga M, Rynko A, Lo DD.
Cytokine. 2009 Jul;47(1):69-76. doi: 10.1016/j.cyto.2009.05.001. Epub 2009 Jun 5.
Prediction of human miRNAs using tissue-selective motifs in 3' UTRs.
Chang YM, Juan HF, Lee TY, Chang YY, Yeh YM, Li WH, Shih AC.
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17061-6. doi: 10.1073/pnas.0809151105. Epub 2008 Oct 24.
Divergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5).
Zboralski D, Böckmann M, Zapatka M, Hoppe S, Schöneck A, Hahn SA, Schmiegel W, Schwarte-Waldhoff I.
BMC Cancer. 2008 Jul 29;8:215. doi: 10.1186/1471-2407-8-215.
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China.
Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K.
J Transl Med. 2008 Jun 20;6:32. doi: 10.1186/1479-5876-6-32.
Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia.
Puigdecanet E, Espinet B, Lozano JJ, Sumoy L, Bellosillo B, Arenillas L, Alvarez-Larrán A, Solé F, Serrano S, Besses C, Florensa L.
Leukemia. 2008 Jul;22(7):1368-76. doi: 10.1038/leu.2008.112. Epub 2008 May 15.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on